Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 3, 1998, Pages 391-396

  Goldstein, Ellie J C ^a,b,c   Citron, Diane M ^a,b   Hudspeth, Marie ^a,b   Gerardo, Sharon Hunt ^a,b   Vreni Merriam, C ^a,b  

^a Santa Monica UCLA Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEROIDES; BITE; NONHUMAN; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BITES AND STINGS; BITES, HUMAN; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; OFLOXACIN; SPECIES SPECIFICITY; WOUND INFECTION;

EID: 0031946868     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.3.391     Document Type: Article

References (10)

1. Goldstein, E. J. C. (1992). Bite wounds and infection. Clinical Infectious Diseases 14, 633-8.
2. Goldstein, E. J. C., Citron, D. M., Wield, B., Blachman, U., Suiter, V. L, Miller, T. A. et al. (1978). Bacteriology of human and animal bite wounds. Journal of Clinical Microbiology 8,667-72.
3. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1994). Activity of CP 99,219 compared with those of ciprofjoxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrobial Agents and Chemotherapy 38,2471-6.
4. Wexler, H. M., Molitoris, E., Molitoris, D. & Finegold, S. M. (1996). In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrobial Agents and Chemotherapy 40, 2232-5.
5. Hoist, E., Rollof, J., Larsson, L. & Nielsen. J. P. (1992). Characterization and distribution of Pasteurella species recovered from infected humans. Journal of Clinical Microbiology 30, 2984-7.
6. Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H. (1995). Manual of Clinical Microbiology, 6th edn. American Society for Microbiology, Washington, DC.
7. National Committee for Clinical Laboratory Standards. (1993). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria - Third Edition; Approved Standard M11-A3. NCCLS, Villanova, PA.
8. National Committee for Clinical Laboratory Standards. (1993). Method for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-A3. NCCLS, Villanova. PA.
9. Goldstein, E. J. C. & Citron, D. M. (1993). Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. Antimicrobial Agents and Chemotherapy 37,1150-3.
10. Alexander, C. J., Citron, D. M., Gerardo, S. H., Claras, M. C., Talan, D. & Goldstein E. J. C. (1997). Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. Journal of Clinical Microbiology 35, 406-11.